Literature DB >> 284413

Nucleolar antigen found in several human tumors but not in the nontumor tissues studied.

F M Davis, F Gyorkey, R K Busch, H Busch.   

Abstract

Rabbit antibodies to nucleoli isolated from HeLa cells produced bright nucleolar fluorescence in HeLa cells by the indirect immunofluorescence technique. After absorption with fetal bovine serum and placental nuclei, the IgG still produced bright nucleolar fluorescence in 12 human tumor cells including HeLa, HEp-2, cultures of prostate and mammary carcinomas, the Goldenberg GW-39 colon tumor, and biopsy specimens of prostatic, adrenal cortical, thyroid, and squamous cell carcinomas, a hairy cell leukemia of the spleen, a hepatic metastasis of an adenocarcinoma of the colon, and an osteogenic sarcoma. Bright nucleolar fluorescence was not produced in nine nontumor human cells including biopsy specimens of bone marrow, kidney, placenta, thyroid, liver, and prostate, peripheral blood buffy coat, and cultures of normal skin fibroblasts. Nucleolar fluorescence with the absorbed IgG was prevented in HeLa cells by pretreatment of the cells with acid, base, and proteases but not by pretreatment with nucleases; absorption of this IgG with extracts of HeLa nucleoli prevented the nucleolor fluorescence in HeLa and other human tumor cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 284413      PMCID: PMC383084          DOI: 10.1073/pnas.76.2.892

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  Fractionation of nucleoli. Enzymatic and two-dimensional polyacrylamide gel electrophoretic analysis.

Authors:  L I Rothblum; P M Mamrack; H M Kunkle; M O Olson; H Busch
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

2.  Differences among 100-A filamentilament subunits from different cell types.

Authors:  G S Bennett; S A Fellini; J M Croop; J J Otto; J Bryan; H Holtzer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

3.  Rabbit antibodies to nucleoli of Novikoff hepatoma and normal liver of the rat.

Authors:  R K Busch; I Daskal; W H Spohn; M Kellermayer; H Busch
Journal:  Cancer Res       Date:  1974-09       Impact factor: 12.701

4.  Comparison of nucleolar proteins of normal rat liver and Novikoff hepatoma ascites cells by two-dimensional polyacrylamide gel electrophoresis.

Authors:  L R Orrick; M O Olson; H Busch
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

5.  Defective organization of actin in cultured skin fibroblasts from patients with inherited adenocarcinoma.

Authors:  L Kopelovich; S Conlon; R Pollack
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

6.  A fetal protein in chromatin of Novikoff hepatoma and Walker 256 carcinosarcoma tumors that is absent from normal and regenerating rat liver.

Authors:  L C Yeoman; J J Jordan; R K Busch; C W Taylor; H E Savage; H Busch
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

7.  A general concept for molecular biology of cancer.

Authors:  H Busch
Journal:  Cancer Res       Date:  1976-11       Impact factor: 12.701

8.  Differences in nucleolar antigens of rat liver and Novikoff hepatoma ascites cells.

Authors:  F M Davis; R K Busch; L C Yeoman; H Busch
Journal:  Cancer Res       Date:  1978-07       Impact factor: 12.701

9.  Nuclear matrix of HeLa S3 cells. Polypeptide composition during adenovirus infection and in phases of the cell cycle.

Authors:  L D Hodge; P Mancini; F M Davis; P Heywood
Journal:  J Cell Biol       Date:  1977-01       Impact factor: 10.539

10.  Fluorescent antibody localization of myosin in the cytoplasm, cleavage furrow, and mitotic spindle of human cells.

Authors:  K Fujiwara; T D Pollard
Journal:  J Cell Biol       Date:  1976-12       Impact factor: 10.539

View more
  10 in total

1.  Double immunoenzymatic labeling of lymphomatous tissues for both immunologic phenotype and a malignancy-associated nucleolar antigen.

Authors:  M Lu; F M Davis; R J Ford
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

2.  Immunohistochemical and biochemical characterization of antisera raised to human tumor nucleoli.

Authors:  R S Greenfield; M O Lamon; L J Olech; J A Grattan
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

3.  Characterization of Novikoff hepatoma small RNAs homologous to repetitive DNAs.

Authors:  R Reddy; D Henning; D Suh
Journal:  Mol Cell Biochem       Date:  1988-02       Impact factor: 3.396

4.  A monoclonal antibody (HO-No-1) with specificity for a human nucleolar protein.

Authors:  Y S Ho; C Z Huang; Y C Tu
Journal:  Br J Exp Pathol       Date:  1987-12

5.  Identification and purification of Namalwa nuclear RNP antigen 52/5.3.

Authors:  K Takahashi; P K Chan; R K Busch; H Busch
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

6.  Enzyme-linked immunosorbent assay for use with nuclear protein-DNA complex antigens.

Authors:  D E Pumo; D Viceps-Madore; J F Chiu
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

7.  Nucleolar immunofluorescence in bone marrow specimens of human hematological malignancies.

Authors:  K Smetana; R K Busch; F Hermansky; H Busch
Journal:  Blut       Date:  1981-02

8.  Proliferating cell nuclear antigen (PCNA) and human malignant tumor nucleolar antigens (HMTNA) in nucleoli of human hematological malignancies.

Authors:  K Smetana; F Gyorkey; P K Chan; E Tan; H Busch
Journal:  Blut       Date:  1983-03

9.  Isolation and partial characterization of a nuclear antigen (68/6.3) from the Namalwa cell line (a Burkitt lymphoma).

Authors:  P K Chan; R L Frakes; R K Busch; H Busch
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

10.  Immunological localization of a major karyoskeletal protein in nucleoli of oocytes and somatic cells of Xenopus laevis.

Authors:  G Krohne; R Stick; J A Kleinschmidt; R Moll; W W Franke; P Hausen
Journal:  J Cell Biol       Date:  1982-09       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.